Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cryotechnology for removing necrotic pancreatic tissue

Official title: Necrosectomy With Cryotechnology for Accelerated Removal

Run by Brigham and Women's Hospital · NCT06553651 · Data updated 2026-11-12

This study is testing a new freezing technique to see if it can help doctors remove dead tissue from the pancreas more effectively in patients with severe pancreatitis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedDecember 2026
Main results expectedDecember 2028
Study endsJune 2029
Registry record updatedJune 25, 2026
Trial IDNCT06553651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with symptomatic pancreatic necrosis resulting from acute pancreatitis and significant necrotic material as indicated by imaging.

Probably not a fit

Patients who are unable to provide informed consent or have contraindications such as significant vascular issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of cryotechnology in conjunction with direct endoscopic necrosectomy (DEN) to enhance the removal of necrotic pancreatic tissue in patients suffering from pancreatic necrosis due to acute pancreatitis. The procedure aims to improve the effectiveness of current endoscopic methods, which often struggle with sticky necrotic tissue. Participants will undergo repeated endoscopic procedures to assess the efficacy and safety of this innovative approach. The study is designed to provide insights into better management strategies for a condition that carries significant morbidity and mortality.

Why it matters

Potential benefit: If successful, this approach could lead to more effective and safer treatment options for patients with pancreatic necrosis.

How similar studies have gone: While the use of cryotechnology in this context is relatively novel, similar endoscopic approaches have shown promise in managing pancreatic necrosis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects aged 18 years and above, inclusive of both males and females.
* Patients with symptomatic pancreatic necrosis resulting from acute pancreatitis, indicated for endoscopic necrosectomy following endoscopic ultrasound (EUS)-guided drainage.
* Imaging indicative of ≥30% necrotic material within the pancreas.
* Walled-off pancreatic necrosis (WOPN) size ≥6 cm.
* Subjects able to tolerate repeated endoscopic procedures.
* Capacity for providing informed consent.
* Understanding of study requirements, provision of written informed consent, and willingness and ability to attend required follow-up assessments through 21 (+/- 7) days.

Exclusion Criteria:

* Inability to provide informed consent.
* Unwillingness to undergo repeated endoscopies.
* Presence of documented Pseudoaneurysm \> 1cm within the WOPN.
* Intervening gastric varices or unavoidable blood vessels within the access tract.
* Use of dual antiplatelet therapy or therapeutic anticoagulation that cannot be temporarily discontinued.
* Any condition deemed by the investigator to compromise the safety of undergoing an endoscopic procedure.
* Pregnancy, lactation, or absence of reliable contraception in women of childbearing potential.
* Current enrollment in another investigational trial with potential to interfere with this study's endpoint analyses.

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher C. Thompson, MD, MSc — Brigham and Womens Hospital
  • Study coordinator: Michele Ryan, MS
  • Email: mryan@bwh.harvard.edu
  • Phone: 617-525-8266

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.